Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused

Even several months after the start of a massive vaccination campaign against COVID-19, mortality and hospital admission are still high in many countries. Monoclonal antibodies against SARS-CoV-2 are the ideal complement to vaccination in infected subjects who are at high risk for progression to sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentile, Ivan, Maraolo, Alberto Enrico, Buonomo, Antonio Riccardo, Nobile, Mariano, Piscitelli, Prisco, Miani, Alessandro, Schiano Moriello, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583134/
https://www.ncbi.nlm.nih.gov/pubmed/34769678
http://dx.doi.org/10.3390/ijerph182111159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583134/
https://www.ncbi.nlm.nih.gov/pubmed/34769678
http://dx.doi.org/10.3390/ijerph182111159

Ejemplares similares